Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Archives of Dermatological Research

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00403-013-1431-9PMID 24292093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum levels of ADAM12‐S: possible association with the initiation and progression of dermal fibrosis and interstitial lung disease in patients with systemic sclerosis

  2013cited by this paper
• Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.

  2013cited by this paper
• Clinical significance of serum retinol binding protein‐4 levels in patients with systemic sclerosis

  2013cited by this paper
• A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response.

  2013cited by this paper
• Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis

  2012cited by this paper
• A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis

  2012cited by this paper
• Clinical significance of serum decoy receptor 3 levels in patients with systemic sclerosis.

  2012cited by this paper
• Serum Levels of Galectin-3: Possible Association with Fibrosis, Aberrant Angiogenesis, and Immune Activation in Patients with Systemic Sclerosis

  2012cited by this paper
• Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma

  2012cited by this paper
• Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization

  2011cited by this paper
• Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis

  2010cited by this paper
• Future treatments in systemic sclerosis

  2010cited by this paper
• Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy.

  2010cited by this paper
• Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients

  2009cited by this paper
• Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?

  2008cited by this paper
• Transforming Growth Factor-β Regulates DNA Binding Activity of Transcription Factor Fli1 by p300/CREB-binding Protein-associated Factor-dependent Acetylation*

  2007cited by this paper
• Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.

  2006cited by this paper
• Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis.

  2005cited by this paper
• Elevated matrix metalloproteinase-9 in patients with systemic sclerosis

  2004cited by this paper
• Chemokines and chemokine receptors: their manifold roles in homeostasis and disease.

  2004cited by this paper
• Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.

  2003cited by this paper
• Chemokine-Cytokine Cross-talk

  2003cited by this paper
• CXC chemokines in angiogenesis

  2000cited by this paper
• Release of CXC‐chemokines by human lung microvascular endothelial cells (LMVEC) compared with macrovascular umbilical vein endothelial cells

  1999cited by this paper
• The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis.

  1999cited by this paper
• Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis

  1997cited by this paper
• Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis.

  1997cited by this paper
• Human endothelial cells synthesize ENA-78: relationship to IL-8 and to signaling of PMN adhesion.

  1997cited by this paper
• The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease.

  1997cited by this paper
• Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis.

  1995cited by this paper
• Interleukin-8 and neutrophils in systemic sclerosis with lung involvement.

  1994cited by this paper
• Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis.

  1994cited by this paper
• Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

  1993cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper

• Role of Transcription Factor Fli-1 in Inflammation and Autoimmune Diseases

  2025cites this paper
• What have we learned on pre, very early, and early systemic sclerosis microcirculatory pathophysiology? A scoping review.

  2024cites this paper
• FLI-1-driven regulation of endothelial cells in human diseases

  2024cites this paper
• Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review

  2023cites this paper
• Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis

  2023cites this paper
• The Role of CCL24 in Systemic Sclerosis

  2023cites this paper
• Fli1 and Tissue Fibrosis in Various Diseases

  2023cites this paper
• Endothelial CCR6 Expression Due to FLI1 De�ciency Contributes to Vasculopathy Associated with Systemic Sclerosis

  2021cites this paper
• Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis

  2021cites this paper
• Serum vasohibin‐1 levels: A potential marker of dermal and pulmonary fibrosis in systemic sclerosis

  2021cites this paper
• Fli1 deficiency suppresses RALDH1 activity of dermal dendritic cells and related induction of regulatory T cells: a possible role in scleroderma

  2020cites this paper
• Epigenetics in Allergy and Autoimmunity

  2020cites this paper
• The Epigenetic Regulation of Scleroderma and Its Clinical Application.

  2020cites this paper
• Emerging role of Fli1 in autoimmune diseases.

  2020cites this paper
• A potential contribution of trappin‐2 to the development of vasculopathy in systemic sclerosis

  2019cites this paper
• A potential contribution of decreased galectin‐7 expression in stratified epithelia to the development of cutaneous and oesophageal manifestations in systemic sclerosis

  2019cites this paper
• Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.

  2019cites this paper
• Possible association of decreased serum CXCL14 levels with digital ulcers in patients with systemic sclerosis

  2019cites this paper
• Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis

  2019cites this paper
• Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.

  2019cites this paper
• Cyclophosphamide Pulse Therapy Normalizes Vascular Abnormalities in a Mouse Model of Systemic Sclerosis Vasculopathy.

  2019cites this paper
• Epigenetics and pathogenesis of systemic sclerosis; the ins and outs.

  2018cites this paper
• Downregulation of ERG and FLI1 expression in endothelial cells triggers endothelial-to-mesenchymal transition

  2018cites this paper
• Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma.

  2018cites this paper
• Systemic sclerosis

  2018cites this paper
• Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells

  2018cites this paper
• Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview

  2017cites this paper
• Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis

  2017cites this paper
• Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency.

  2017cites this paper
• Vasculopathy in Systemic Sclerosis Endothelial Cells , Contributing to the Development of Fibrosis and Fli 1 Deficiency Induces CXCL 6 Expression in Dermal Fibroblasts and

  2017cites this paper
• The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.

  2017cites this paper
• A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis

  2017cites this paper
• Inflammation and Immunity

  2017cites this paper
• Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors

  2016cites this paper
• Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions

  2016cites this paper
• A potential contribution of antimicrobial peptide LL‐37 to tissue fibrosis and vasculopathy in systemic sclerosis

  2016cites this paper
• Acetylation impacts Fli‐1‐driven regulation of granulocyte colony stimulating factor

  2016cites this paper
• A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis

  2016cites this paper
• Serum levels of interleukin‐18‐binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis

  2016cites this paper
• Recent advances in animal models of systemic sclerosis

  2016cites this paper
• Endothelin Receptor Blockade Ameliorates Vascular Fragility in Endothelial Cell–Specific Fli‐1–Knockout Mice by Increasing Fli‐1 DNA Binding Ability

  2015cites this paper
• A possible contribution of lipocalin‐2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis

  2015cites this paper
• Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis.

  2015cites this paper
• Progranulin Overproduction Due to Fli‐1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis

  2015cites this paper
• A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis

  2015cites this paper
• Fli1 deficiency and beyond: a unique pathway linking peripheral vasculopathy and dermal fibrosis in systemic sclerosis

  2015cites this paper
• Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.

  2015cites this paper
• Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis.

  2015cites this paper
• Endothelial dysfunction in systemic sclerosis

  2014cites this paper